Annual healthcare costs jump by almost $25,000 with targeted therapy for atopic dermatitis that avoided costs from reduced hospitalizations and ER visits only partly offset, according to recently reported research findings.
News|Videos|September 9, 2023
- MHE September 2023
- Volume 33
- Issue 9
We've All Got a Guilty Pleasure. Kyna Fong of Elation Health Says Her's Starts With Her Sweet Tooth
Author(s)Briana Contreras
Kyna Fong, Ph.D., CEO and co-founder, Elation Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Fong shared a guilty pleasure of her's is Na Ya Dessert Cafe in San Francisco's Hayes Valley. In addition to a guilty pleasure, Fong also talked about a career turning point she experienced, and what book she recommends to healthcare professionals.
Advertisement
Articles in this issue
about 3 years ago
Sickle Cell Disease Finally Getting its Dueabout 3 years ago
Ghost Network Bustersabout 3 years ago
A Snack in Bed Could Cure the Woes of Working in Healthcareabout 3 years ago
Emerging Leaders in Healthcare: Hannah Ratcliffe of WaymarkAdvertisement
Related to this article
Findings from an analysis of IQVIA claims data show a prevalence rate that is five times lower than previous reports. Some of the discrepancy could be chalked up to the difference between using claims data instead of self-reporting by survey respondents.
In the MDT-BRIDGE trial, 92% of patients with stage II-III lung cancer reached surgery or chemoradiation after a midtreatment tumor board review.
Epic Research finds over half of children with type 1 diabetes miss autoantibody testing, risking misdiagnosis and limiting early treatment options like Tzield.
Higher MRI-measured liver disease activity was linked to lower quality of life and more anxiety and activity problems in 802 adults with suspected MASLD/MASH in Europe.
Teen boys with obesity and lower baseline fitness were less likely to see MASLD resolve during a lifestyle program, a Belgian study found.
MassHealth's Katelyn Meyer, Pharm.D., says mandatory coverage, young patients and an unpredictable FDA make planning for new specialty drugs a challenge.
A truly transparent PBM arrangement starts with full disclosure of direct and indirect compensation.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New pulmonary fibrosis drugs put guidelines in focus, Prusi says | AMCP Nexus 2026
2
The ripple effects of Medicare’s maximum fair price with Hiva Pourarsalan, Pharm.D. | AMCP Nexus 2026
3
Fewer than half of newly diagnosed children with type 1 diabetes get autoantibody testing
4
How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study
5